Rocket Pharmaceuticals Announces Executive and Board Appointments
Ticker: RCKTW · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-appointments, personnel
TL;DR
Rocket Pharma beefs up exec team & board with Leff, Kelly, Epstein, and Miller.
AI Summary
Rocket Pharmaceuticals, Inc. announced on July 7, 2025, a series of executive and board changes. Dr. Jonathan Leff has been appointed as Chief Medical Officer, and Ms. Sarah Kelly has joined as Chief Business Officer. Additionally, Mr. David Epstein and Ms. Susan Miller have been elected to the Board of Directors.
Why It Matters
These appointments bring new leadership and expertise to Rocket Pharmaceuticals, potentially impacting the company's strategic direction and drug development pipeline.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Rocket Pharmaceuticals, Inc. (company) — Registrant
- Jonathan Leff (person) — Appointed Chief Medical Officer
- Sarah Kelly (person) — Appointed Chief Business Officer
- David Epstein (person) — Elected to Board of Directors
- Susan Miller (person) — Elected to Board of Directors
- July 7, 2025 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Jonathan Leff has been appointed as the Chief Medical Officer.
What is the new role of Ms. Sarah Kelly?
Ms. Sarah Kelly has been appointed as the Chief Business Officer.
Who were elected to the Board of Directors?
Mr. David Epstein and Ms. Susan Miller were elected to the Board of Directors.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is July 7, 2025.
In which state is Rocket Pharmaceuticals, Inc. incorporated?
Rocket Pharmaceuticals, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 by Jonathan Leff regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).